Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
ID05942430

Evaluation of the Effectiveness and Safety of Autologous Costal Osteochondral Transplantation in the Treatment of Talar Osteochondral Lesions: a Randomized Controlled Clinical Trial

Led by The Third Affiliated Hospital of Southern Medical University · Updated on 2023-09-06

50

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness and safety of autologous costal osteochondral transplantation compared with autologous osteoperiosteal transplantation in treating Hepple Stage V talar osteochondral lesions. The main goal is to determine if the costal osteochondral transplantation can provide better clinical outcomes and improved cartilage repair with fewer donor site complications than the osteoperiosteal transplantation. Participants will be randomly assigned to one of these two surgical treatments. The study involves two treatment groups: one receiving the autologous costal osteochondral transplantation, which includes harvesting an osteochondral column from the rib and implanting it into the talar defect, and the other receiving autologous iliac osteoperiosteal transplantation, which involves obtaining a cylindrical osteoperiosteal column from the iliac crest for implantation. Both surgeries include removing the talar lesion, filling the cavity with cancellous bone, and ensuring the transplant surface aligns with the surrounding cartilage. After surgery, all participants will follow the same rehabilitation and follow-up plan. Participants will be monitored over time with various assessments including the American Orthopedic Foot and Ankle Society (AOFAS) ankle-hindfoot scale at multiple intervals up to 24 months after surgery. Additional measures include pain ratings during walking, cartilage repair evaluations by MRI, functional scores, bone healing, patient satisfaction, and monitoring for any complications. The study aims to collect detailed data on clinical outcomes and safety over two years following the surgical treatment.

CONDITIONS

Brief Title

Autologous Costal Osteochondral Transplantation for Talar Osteochondral Lesions

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Symptomatic Hepple stage V talar osteochondral lesions with a lesion depth 5 mm and an AOFAS score 580 points
  • Failed conservative treatment for at least 6 months
  • Unilateral talar osteochondral lesions without corresponding lesions on the tibial side
  • Willingness to participate in this clinical trial and signing an informed consent form
Not Eligible

You will not qualify if you...

  • Combined with lower limb deformity
  • Combined with hip or knee joint diseases
  • Combined with ipsilateral ankle arthritis with joint space narrowing
  • Diagnosis of gouty arthritis of the ankle joint
  • Combined with osteoporosis (T score <-2.5)
  • Other conditions considered inappropriate for participation in this clinical trial by the researchers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Surgery day and initial recovery period

Participants undergo surgery to receive either autologous costal osteochondral transplantation or autologous iliac osteoperiosteal transplantation to repair talar osteochondral lesions, followed by immediate post-operative care.

1 surgery visit plus immediate post-operative care visits

Post-operative Follow-up

Duration - Up to 24 months after surgery

Participants are monitored after surgery to assess recovery, bone union, pain levels, joint function, cartilage repair, and any complications.

Multiple visits at 1, 2, 3, 6, 12, and 24 months after surgery

Trial Site Locations

Total: 1 location

1

The Third Affiliated Hospital of Southern Medical University

Guangzhou, Guangdong, China, 510630

Actively Recruiting

Loading map...

Research Team

H

Hao Guo, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Prospective, Open-label, Randomized, Controlled Phase 3 St...

Chondral Defect

Actively Recruiting

12 locations

A Prospective, Open-label, Randomized, Active-controlled Pha...

Chondral Defect

Actively Recruiting

4 locations

Autologous Matrix-Induced Chondrogenesis Compared With Micro...

Hip Arthroscopy

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here